DJIA 17,081.89 -49.97 -0.29%
NASDAQ 4,796.61 -42.03 -0.87%
S&P 500 2,003.69 -13.77 -0.68%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

40.80 -1.40 (-3.32%)

REAL-TIME: Last trade at

Extended Hours: $40.79 -$0.01 (-0.02%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

ISIS $40.80 -3.32%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $41.89
Previous Close $42.20
Daily Range $40.74 - $43.59
52-Week Range $35.26 - $77.80
Market Cap $4.9B
P/E Ratio 222.11
Dividend (Yield) $0.00 (0.0%)
Volume 1,229,086
Average Daily Volume 1,856,370
Current FY EPS -$0.55




Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary

These Big Pharma Companies Are in Need of an Acquisition

The patent cliff crushed these Big Pharma companies, and now their only opportunity for sustainable growth might be to go shopping for a rival.

3 Reasons ISIS Pharmaceuticals Is a Buy

An enviable pipeline and a lower valuation make may now a good time to pick up shares in this RNA leader.

Here's Why Isis Pharmaceuticals' Stock Shed 19% of its Value in September

Isis Pharmaceuticals followed the broader biotech sector lower in September. Should investors take advantage of this pullback or stay on the sidelines?

ISIS Pharmaceuticals (ISIS) Flagged As Strong On High Volume

Highlighted Post-Market Laggard: ISIS Pharmaceuticals (ISIS)

Isis Pharmaceuticals is Now Oversold (ISIS)

Bio Blast - Small Company With Multiple Interesting Orphan Drug Platforms

Benzinga's Top Initiations

ISIS Pharmaceuticals (ISIS) Falls Further As It's Water-Logged And Getting Wetter

Is It Time to Kick These Healthcare Laggards Out of Your Portfolio?

The time may be right to give these 3 healthcare stocks the boot.

See More ISIS News...

ISIS's Top Competitors

ISIS $40.80 (-3.32%)
Current stock: ISIS
AMGN $147.58 (-3.56%)
Current stock: AMGN
GILD $98.19 (-1.33%)
Current stock: GILD
BIIB $256.04 (-3.26%)
Current stock: BIIB